Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: Lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues-Reference-Cited by-同舟云学术

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: Lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues

Published:2014-02 Issue:2 Volume:83 Page:289-296
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Pace Leonardo,Nicolai Emanuele,Luongo Angelo,Aiello Marco,Catalano Onofrio A.,Soricelli Andrea,Salvatore Marco

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. PET diagnostic accuracy: improvement within-line PET–CT system: initial results;Hany;Radiology,2002

2. PET/CT: the current technology and applications;Mittra;Radiol Clin North Am,2009

3. Whole-body PET/MRI: the future in oncological imaging;Seemann;Technol Cancer Res Treat,2005

4. A look ahead: PET/MR versus PET/CT;von Schulthess;Eur J Nucl Med Mol Imaging,2009

5. PET/MRI: challenges, solutions and perspectives;Herzog;Z Med Phys,2012

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Results of PET/MRI Diagnostic Method in Breast Cancer Diagnosis: A Systematic Review;Indian Journal of Gynecologic Oncology;2024-08-03

2. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

3. PET/CT in comparison with PET/MRI as an imaging modality in the management of Gliomas–A systematic review and meta analysis;Journal of Medical Imaging and Radiation Sciences;2024-03

4. The Clinical Added Value of Breast Cancer Imaging Using Hybrid PET/MR Imaging;Magnetic Resonance Imaging Clinics of North America;2023-11

5. Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results;European Journal of Radiology;2023-10